Open AccessAccumulation of p62 is associated with poor prognosis in patients with triple-negative breast cancer
Author(s) -
Zhong-Yu Yuan,
Luo,
Mei Li,
Shaoyan Xi,
Jia Fu,
He
Publication year - 2013
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s46222
Subject(s) - triple negative breast cancer , medicine , oncology , lymphovascular invasion , breast cancer , immunohistochemistry , tissue microarray , stage (stratigraphy) , proportional hazards model , overall survival , cancer , metastasis , biology , paleontology
Triple-negative breast cancer (TNBC) is associated with poor prognosis. There is an urgent need for elucidation of novel targets for TNBC therapy and to improve the prognosis of patients. The aim of this study was to evaluate the prognostic value of p62 expression in TNBC.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom